1. Home
  2. VWAV vs KPTI Comparison

VWAV vs KPTI Comparison

Compare VWAV & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VWAV

VisionWave Holdings Inc.

N/A

Current Price

$7.28

Market Cap

146.0M

Sector

Technology

ML Signal

N/A

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

N/A

Current Price

$8.77

Market Cap

172.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VWAV
KPTI
Founded
2024
2008
Country
United States
United States
Employees
12
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.0M
172.6M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
VWAV
KPTI
Price
$7.28
$8.77
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$17.50
AVG Volume (30 Days)
234.3K
783.7K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$146,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$46.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.57
52 Week Low
$2.06
$3.51
52 Week High
$15.80
$10.99

Technical Indicators

Market Signals
Indicator
VWAV
KPTI
Relative Strength Index (RSI) 39.96 52.67
Support Level $6.80 $5.60
Resistance Level $8.70 $8.95
Average True Range (ATR) 0.58 0.69
MACD 0.03 -0.19
Stochastic Oscillator 29.75 26.19

Price Performance

Historical Comparison
VWAV
KPTI

About VWAV VisionWave Holdings Inc.

VisionWave Holdings Inc is a technology company focused on the development and commercialization of artificial intelligence (AI) and autonomous solutions across air, ground and sea environments. Through its subsidiary, the Company designs and deploys technologies including radars, radio frequency (RF) sensing, unmanned aerial and ground systems, remote weapon stations and active protection systems for defense, military, homeland security and industrial applications. Its proprietary AI engine supports autonomous decision-making and product lines at various stages of development and commercialization. Revenue is generated through product sales, technology licensing, strategic alliances and joint ventures, with products including C-UAS, multi-purpose autonomous UAS and Vision-AI technology.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: